Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the buyer’s cancer pipeline with that of Terns—led by an oral tyrosine kinase ...

The Hong Kong biotechnology company created a subsidiary focused on researching and commercializing therapeutic immunotherapy products for oncology.

Muscles age differently than you think. Discover the science behind the aging muscle paradox—and how exercise can help you ...

CEO Jasbir Seehra outlined the company’s development priorities and partnership plans during a presentation at Oppenheimer’s ...

The COVID-19 vaccine produced by Moderna Therapeutics Inc has brought the Massachusetts biopharmaceuticals company billions of dollars in sales, much of that through purchases of its shots by the US ...

Figure 2: Binding of B7-H1 to CTLA4, ICOS and CD28. We measured the amounts of IL-2, IL-4, IFN-γ and IL-10 produced by T cells after stimulation with B7-H1Ig, B7-1 immunoglobulin (B7-1Ig) and ...

Strong capital position of $667.2 million in cash, cash equivalents and short-term investments, together with $180 million in anticipated collaboration payments, expected to support advancement of ...